• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • Experts on Demand
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Effective Competitive Intelligence: A “How-To” Guide for Life Science Companies

$195.00 – $995.00

Clear
SKU: KLI1807610 Category: Pharmaceuticals Market Research Pages: 100
  • Description
  • Table of Contents
  • Latest reports

Description

Often what separates successful marketing from bad is good competitive intelligence. This is true in life sciences as much as other industries. Many companies approach CI in a way that is unplanned, indirect and harmful to their business. But how does one know if they are conducting their company’s CI in the best way?

If you are trying to determine how to use competitive intelligence better, if you are attempting to judge your efforts compared to companies that have been successful, and if you want to know what computer resources might assist you, this guide can help. If you want to get more attention for CI in your organization, and develop a professional and worthwhile approach, this guide is the most useful, current and relevant published on the subject.

Prepared by Dr. Laura Ruth, PhD and the experts at Fuld & Company, jointly published with Kalorama Information, a premier life sciences market research publisher, can assist executives in the life science tasked with implementing competitive intelligence activities.

The utility and power of competitive intelligence for improving decision-making for strategy, operations, and tactical applications comes from knowing what CI can and cannot do and how it fits into the spectrum of widely used market analysis techniques. Data from a 2007 CI benchmarking survey from Fuld & Company, ‘From Stick Fetchers to World Class™’ indicates that CI is part of many pharmaceutical and biotechnology companies. The pharmaceutical and biotech companies are spending anywhere from less than $100,000 dollars to more than $2 million dollars. The years of experience the information in this guide represents is intended for anyone in the life sciences using CI, such as brand managers, R&D managers, regulatory affairs, or investor relations, who is either learning about CI for the first time or building on information they already know.

Highlights:

  • Definition, uses, and anecdotes of what CI is from veteran CI professionals
  • Tips, experience, and insight about the use of the Internet for CI
  • How to use CI as part of strategy analysis
  • Information about how CI software can help a CI research and analysis process
  • Evaluating and improving the quality and efficiency of a CI process
  • Glossary of over 100 CI terms

The information that follows has been collected from Fuld & Company thanks to the help and contributions from many of the staff. Fuld & Company opened its doors in 1979 and is the first and oldest competitive intelligence firm. Leonard Fuld, founder and president, is a pioneer of CI. The launch of the Pharma-Healthcare I3® (Internet Intelligence Index), a comprehensive online index of over 250 CI links, in January 2007, is just one of the many innovative intelligence resources the firm has created. Other CI resources created include intelligence-gathering techniques and books. Mr. Fuld has also continuously shared his innovative thinking for the last 30 years in Academy of Competitive Intelligence classes, lectures around the world, and with his staff.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Highlights

CHAPTER TWO: INTRODUCTION

What Competitive Intelligence Is and Is Not!

Insight from CI Veterans

CHAPTER THREE: COMPETITIVE INTELLIGENCE “HOW-TO

Secondary Searching Insight

Internet Tips & Techniques

Using CI for Strategy Analysis

Visual Data Interpretation

War Games

War Game Examples

Scenario Workshop Example

CHAPTER FOUR: CI SOFTWARE – WHAT IT DOES? HOW IT CAN HELP? HOW TO EVALUATE?

Fuld & Company Intelligence Software Report® 2006-2007

Intelligence Cycle Step 1: Planning & Direction

Intelligence Cycle Step 2: Published Information

Intelligence Cycle Step 3: Primary Source

Intelligence Cycle Step 4: Analysis & Production

Intelligence Cycle Step 5: Report & Inform

Theoretical Case Study: Beware – what could go wrong

Intelligence Technology Checklist

CHAPTER FIVE: GETTING HELP WITH CI PROCESSES:

IMPLEMENTING AND IMPROVING

CHAPTER SIX: INTELLIGENCE VOCABULARY

APPENDIX: FULD & COMPANY SERVICES

 

    Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals
    May 22, 2023
    Precision Cancer Therapeutics Market, 2022
    October 25, 2022
    The World Market for Vaccines, 2022-2027
    September 23, 2022
    Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022
    August 2, 2022

Related products

  • Placeholder image

    Rheumatoid Arthritis: The 45 Market in the United States for Drugs and Biologics

    $2,246.00 – $4,492.00
  • Placeholder image

    Medicare Reform and the Pharmaceutical Industry: Implications of the Medicare Prescription Drug Improvement and Modernization Act of 2003

    $795.00 – $1,590.00
  • Placeholder image

    World Market for Anti-infectives Volume III: The World Market for Antiviral Medications, The

    $1,875.00 – $3,750.00
  • Placeholder image

    OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition

    $1,496.00 – $2,992.00

Contact Us

  •  Email Us: Customer Service

  •  Phone (US):  703-778-3080

  •  Fax:  703-778-3081

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • How Globalization and Climate Change Impact COVID-19 and the IVD Market September 20, 2023
  • IVD Trends 2023-2028: Emerging Growth Markets in Asia, Latin America, and the Middle East September 15, 2023
  • Worldwide IVD: 8 Key Trends to Watch in $106 Billion Market September 6, 2023
  • The Wide-Reaching Potential of Artificial Intelligence in Healthcare August 28, 2023
  • IVD for Pets: A $2.7 Billion Global Market July 24, 2023

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis...Glucose Testing Markets
Scroll to top